Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis - Wikidata - awgldk - TriplyDB

Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

http://www.wikidata.org/entity/Q37169713

about

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.Clinical and Pathologic Remission of Pediatric Ulcerative Colitis with Serum-Derived Bovine Immunoglobulin Added to the Standard Treatment Regimen New proteomic approaches for biomarker discovery in inflammatory bowel disease.Therapeutic efficacy of pH-dependent release formulation of mesalazine on active ulcerative colitis resistant to time-dependent release formulation: analysis of fecal calprotectin concentration High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitis Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.Utility of faecal calprotectin analysis in adult inflammatory bowel disease.Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease.Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.Biomarkers in management of inflammatory bowel disease.Methods to determine intestinal permeability and bacterial translocation during liver disease.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Study.Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis Update on current applications of proteomic in the study of inflammatory bowel disease.Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting

P2860

Q24608254-F075CEE3-C39D-4CB7-9FFE-88461BF827EF Q26768280-7A40F90B-85E4-4E0B-9D6D-360C34D24E7C Q26773267-2D514755-2F1E-4733-BBB3-BCF0F61A9F79 Q33458873-75744206-D726-402B-89DB-988597BF7869 Q33801631-CC734739-A6B9-4606-BF2B-F2D7A6DDD46B Q34096526-375FD751-FD01-41C1-BAF8-710688701178 Q34608415-6EBDC9E0-D331-4B53-9811-BC018CF7F644 Q34631685-2F1A7389-AE3D-49DE-9A01-CFDE72399685 Q36401625-A2B87700-EC7E-4E14-BC91-483609C5C9D3 Q36456333-5364A7C6-15ED-42CE-B507-93F00E2B42DC Q36461010-41EC825E-0AFC-4542-A051-75995EF05DFE Q37698973-9A27F900-A333-4462-87E9-5811491F6C09 Q37825812-DAC082A8-7897-4B28-A800-8335ECE12EF0 Q37937183-7EC7A8CD-3B2B-4F97-B547-2ABF82F6E649 Q38215501-E6BF4981-31D9-41EA-BB4C-9F6C5218F2A4 Q38321290-4E064633-01B6-4170-A0BC-411B446F7899 Q38742261-542CB6C8-24B0-4FD9-A182-9F2BD3E9C450 Q39179611-307101F8-5E40-46B6-8922-AD08CF447A37 Q40295402-329078C6-1789-4CE6-9495-8D37A7CDF404 Q40694867-F5818836-E779-47D8-B160-D53A48BA110C Q41253670-4978EB7B-1D71-47FF-9CB8-A474DC14224F Q41958173-C0A69EB1-05C9-4F2B-BEB5-532EE0BF1C10 Q41980696-AC24E301-C217-4E24-8258-C37195FB3DD2 Q42406649-E12992BA-2701-4CFC-B595-BEFEEFCC836E Q42643175-0F51CA29-BED6-4CDE-9417-D7E035C8E527 Q45985720-459179C7-D210-471C-95DF-2367BAC007C3 Q47942430-C13891FA-1E50-457C-9CD7-9E3F40F17DC2 Q50470267-B2A08A36-6B69-4EFE-B873-0FC1E304DB65 Q58760402-CA3A960F-EBB2-43FA-9B69-D0E6268A4460

P2860

Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

http://www.wikidata.org/entity/Q37169713

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical value of fecal calpro ...... activity of ulcerative colitis

@en

Clinical value of fecal calpro ...... ctivity of ulcerative colitis.

@nl

type

label

Clinical value of fecal calpro ...... activity of ulcerative colitis

@en

Clinical value of fecal calpro ...... ctivity of ulcerative colitis.

@nl

prefLabel

Clinical value of fecal calpro ...... activity of ulcerative colitis

@en

Clinical value of fecal calpro ...... ctivity of ulcerative colitis.

@nl

P1433

Q37169713-DDAA8C42-F3B7-494D-B61C-7C68B360A0AC

P1476

Q37169713-09AFADF8-FB36-4267-888F-D79108D969BD

P2093

Q37169713-395DB3EF-763F-41EE-BD47-D6DEB286E0A4

Q37169713-6DF3B5FF-05E8-4BCF-B434-FEA530C20088

Q37169713-913786D8-6C96-4E50-BC28-75078DE300B6

Q37169713-E4C391AA-BED8-42A7-8AC0-C68E0BDB14A0

P2860

Q37169713-09D9B05C-A7A5-487D-9737-0B648BF97583

Q37169713-1CC16C7C-9FC9-456D-BA91-08AC8AC838CD

Q37169713-3A717463-D5DA-41CE-957C-1964D62087F5

Q37169713-3CF3484D-CD7C-4363-9F07-CD53164B8233

Q37169713-4811DB02-93C4-45BD-9B91-52655E81A276

Q37169713-495F8D27-A9F2-4096-8DBA-290405DB1DB0

Q37169713-4E6F2BB2-88D3-45D0-8FE2-0A65E7DA1772

Q37169713-5125D2A5-81FB-4EA4-BF83-5C21D39403CE

Q37169713-5747CC57-9967-4AA2-8987-877F97A0AB45

Q37169713-58B47AA3-09B7-4099-BAF2-875E8A3C418E

P304

Q37169713-CC9284E9-28F3-42EE-BFF7-0FDFDE567B6B

P31

Q37169713-15DB949C-1170-4B16-BFE4-07665D323DB0

P356

Q37169713-D59578EE-F25E-4CCF-A537-1CF3AB529C78

P407

Q37169713-1C1B1B6B-85A8-4397-84D7-F887CC4C6A53

P433

Q37169713-4A01E4F5-8D2B-4528-BAC0-8D18E3EA998F

P478

Q37169713-4A9EC736-4643-4ACD-B068-4D3CE2963755

P577

Q37169713-5306988B-0022-4ADF-A8AA-BDDA93DC43E0

P698

Q37169713-993A54FD-F702-4BFC-9528-3143A3D7EB06

P921

Q37169713-BD1CC840-F98C-4E78-ACAE-C41ADDF1E204

P932

Q37169713-EE7B1988-0717-4CDD-A4E9-D9B309DF0BEB

P356

P1433

World Journal of Gastroenterology

P1476

Clinical value of fecal calpro ...... activity of ulcerative colitis

@en

P2093

Guo-Dong Li

http://www.w3.org/2001/XMLSchema#string

Jun-Ying Xiang

http://www.w3.org/2001/XMLSchema#string

Nan-Ping Xiao

http://www.w3.org/2001/XMLSchema#string

Qin Ouyang

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications.

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

An analysis of 10218 ulcerative colitis cases in China.

Emerging role of calprotectin in gastroenterology.

Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation

Neutrophils, nitrogen oxides, and inflammatory bowel disease.

C-reactive protein as a marker for inflammatory bowel disease.

The emergence of inflammatory bowel disease in the Asian Pacific region.

Functional and clinical aspects of the myelomonocyte protein calprotectin.

P304

53-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.14.53

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18176961

http://www.w3.org/2001/XMLSchema#string

P921

P932

2673391

http://www.w3.org/2001/XMLSchema#string